Sign in

CIK 0001087294

  • Non-accelerated filer
  • Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
Operating
EIN
621765329
Phone
+1 615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Open-market buy Chairman and CEO bought 1,682 shares at an average $6.36 ($10,690)
  2. 4 Open-market buy Director bought 1,682 shares at an average $6.36 ($10,690)
  3. 4 Shares withheld for taxes SVP and Chief Development Off. gave up 1,850 shares (to pay taxes)
  4. 4 Open-market buy Director bought 6,695 shares at an average $6.27 ($42,007)
  5. 4 Open-market buy Director bought 3,846 shares at an average $5.87 ($22,578)
  6. 4 Open-market buy Director bought 3,708 shares at an average $6.15 ($22,790)
  7. 4 Open-market buy Director bought 1,526 shares at an average $6.13 ($9,351)
  8. 4 Open-market buy Chairman and CEO bought 1,526 shares at an average $6.13 ($9,351)
  9. 4 Open-market buy Director bought 3,166 shares at an average $6.11 ($19,336)
  10. 4 Open-market buy Director bought 1,596 shares at an average $6.12 ($9,771)
  11. 4 Grant or award Chief Financial Officer acquired 2,500 shares (grant or award)
  12. 4 Grant or award VP and Chief Compliance Office acquired 3,000 shares (grant or award)
  13. 4 Grant or award Sr VP/Chief Commercial Officer acquired 5,000 shares (grant or award)
  14. 4 Grant or award SVP and Chief Development Off. acquired 25,000 shares (grant or award)
  15. 4 Grant or award Chairman and CEO acquired 100,000 shares (grant or award)
  16. 4 Grant or award Director acquired 1,000 shares (grant or award)
  17. 4 Grant or award Director acquired 1,000 shares (grant or award)
  18. 4 Grant or award Director acquired 1,000 shares (grant or award)
  19. 4 Grant or award Director acquired 1,000 shares (grant or award)
  20. 4 Grant or award Director acquired 5,000 shares (grant or award)

Page 16 of 26 · 512 filings